| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001106 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
2004-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11947218c3f57a71009278648885534a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9be0fef7f078503fb3503f184df11a13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12897bfb9dc63351dcc43eab57d76d41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4650d3778a07ced722875c69f757f4a2 |
| publicationDate |
2009-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7547681-B2 |
| titleOfInvention |
Surface receptor antigen vaccines |
| abstract |
The invention provides compositions and methods directed to cell surface receptor antigen specific vaccines. More specifically, vaccines are provided that induce or enhance host antibody titers specific for cell surface receptor antigens and that include recombinant expression constructs containing nucleic acids encoding a target cell surface receptor antigen and one or more immune response altering molecules, or the expressed products themselves. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11369673-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11352642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529408-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11376316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10563224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389521-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10695417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11149087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504423-B2 |
| priorityDate |
1998-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |